eli lilly glp-1 drug launches pill, kicking off showdown with Novo Nordisk Lilly's three-pronged drug puts obesity
Description
(2021) 33:833844.e5
The website describes the formula as "natural" and "plant-based" with a "non-stimulant" profile
The bundle automatically applies evidence-based UM criteria so you can manage coverage for new agents as soon as those criteria become available
doi:10.1038/s41401-020-0413-7 84
